Several studies have related ARID1A to transcriptional regulation, particularly nuclear hormone-induced transcription and expression of cell-cycle regulators; mutations of ARID1A are frequently seen in hormone-responsive cancers, like breast and ovary cancers [5, 8, 11, 12]. Here, ARID1A is linked to ovarian cancer.